Triamterene and Hydrochlorothiazide
- Product NDC
- 51655-722
- 11-digit product format
- 516550722
- Labeler code
- 51655
- Product ID
- 51655-722_4b955f14-73eb-c4db-e063-6294a90adc8c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamterene and Hydrochlorothiazide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA074821
- Marketing category
- ANDA
- Marketing start
- 2021-06-17
- Substance
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Active strength
- 25; 37.5 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 0J48LPH2TH | HYDROCHLOROTHIAZIDE | 58-93-5 | HYDROCHLOROTHIAZIDE |
| WS821Z52LQ | TRIAMTERENE | 396-01-0 | TRIAMTERENE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51655-722-52 | 51655072252 | 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-722-52) | 30 capsule | 2021-06-17 | No | No | Historical |